BR9707581A - Composicao farmaceutica a base de reina ou de diacerreina processo para sua preparacao e utilizacao de reina ou diacerreina - Google Patents

Composicao farmaceutica a base de reina ou de diacerreina processo para sua preparacao e utilizacao de reina ou diacerreina

Info

Publication number
BR9707581A
BR9707581A BR9707581A BR9707581A BR9707581A BR 9707581 A BR9707581 A BR 9707581A BR 9707581 A BR9707581 A BR 9707581A BR 9707581 A BR9707581 A BR 9707581A BR 9707581 A BR9707581 A BR 9707581A
Authority
BR
Brazil
Prior art keywords
diacerreina
reina
pct
pharmaceutical composition
composition based
Prior art date
Application number
BR9707581A
Other languages
English (en)
Inventor
Cyril Estanove
Alain Prudhomme
Original Assignee
Mazal Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mazal Pharma filed Critical Mazal Pharma
Publication of BR9707581A publication Critical patent/BR9707581A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9707581A 1996-12-23 1997-12-23 Composicao farmaceutica a base de reina ou de diacerreina processo para sua preparacao e utilizacao de reina ou diacerreina BR9707581A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615867A FR2757397B1 (fr) 1996-12-23 1996-12-23 Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
PCT/FR1997/002403 WO1998027965A1 (fr) 1996-12-23 1997-12-23 Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree

Publications (1)

Publication Number Publication Date
BR9707581A true BR9707581A (pt) 1999-07-27

Family

ID=9499012

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707581A BR9707581A (pt) 1996-12-23 1997-12-23 Composicao farmaceutica a base de reina ou de diacerreina processo para sua preparacao e utilizacao de reina ou diacerreina

Country Status (14)

Country Link
US (1) US6124358A (pt)
EP (1) EP0904061B1 (pt)
JP (1) JP4166834B2 (pt)
CN (1) CN1128612C (pt)
AT (1) ATE225649T1 (pt)
BR (1) BR9707581A (pt)
CA (1) CA2247520C (pt)
DE (1) DE69716261T2 (pt)
DK (1) DK0904061T3 (pt)
ES (1) ES2184148T3 (pt)
FR (1) FR2757397B1 (pt)
IL (1) IL125794A (pt)
PT (1) PT904061E (pt)
WO (1) WO1998027965A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270306C (en) * 1999-04-27 2000-09-26 Bernard Charles Sherman Pharmaceutical compositions comprising co-micronized fenofibrate
AR026801A1 (es) * 2000-01-12 2003-02-26 Medidom Lab Sustancias para uso en el tratamiento de la psoriasis
WO2002040053A1 (fr) * 2000-11-17 2002-05-23 Takeda Chemical Industries, Ltd. Preparation pharmaceutique contenant du talc/ du sulfate de baryum
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
FR2821555B1 (fr) * 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
US6797727B2 (en) * 2001-07-16 2004-09-28 Transition Therapeutics Inc. Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases
GB0404953D0 (en) * 2004-03-04 2004-04-07 Arakis Ltd Pro-drugs
WO2006119431A2 (en) 2005-04-29 2006-11-09 The Regents Of The University Of Colorado, A Body Corporate Electromagnetic characterization of tissue
FR2920991A1 (fr) * 2007-09-14 2009-03-20 Wockhardt Ltd Composition a base de diacerheine pour le traitement de l'arthrose
WO2009034558A2 (en) * 2007-09-14 2009-03-19 Wockhardt Research Centre Rhein or diacerein compositions
US20100285114A1 (en) * 2007-09-27 2010-11-11 Rahul Dabre Pharmaceutical compositions of rhein or diacerein
ES2382026T3 (es) * 2007-09-27 2012-06-04 Wockhardt Limited Composiciones farmacéuticas autoemulsionantes de reína o diacereína
AU2013200968B2 (en) * 2007-09-27 2013-11-21 Wockhardt Limited Pharmaceutical compositions of rhein or diacerein
EP2520284A1 (en) * 2007-09-27 2012-11-07 Wockhardt Limited Pharmaceutical compositions of rhein or diacerein
WO2009048940A2 (en) * 2007-10-08 2009-04-16 Dr. Reddy's Laboratories Ltd. Diacerein pharmaceutical formulations
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
US9119819B2 (en) * 2008-04-30 2015-09-01 Wockhardt Ltd. Oral liquid compositions of rhein or diacerein
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
US20110045522A1 (en) * 2009-08-20 2011-02-24 Danchen Gao Methods for diagnosing diabetes and determining effectiveness of treatments
CN101822660B (zh) * 2010-05-13 2013-07-10 中国人民解放军肾脏病研究所 大黄酸类化合物或其盐在制备预防和治疗胰岛β细胞功能衰退药物中的应用
WO2013095319A2 (en) 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations of flurbiprofen and diacerein
US9814448B2 (en) 2012-05-21 2017-11-14 Precision Biopsy, Inc. Three-dimensional optical imaging and therapy of prostate cancer
WO2013177061A1 (en) 2012-05-21 2013-11-28 The Regents Of The University Of Colorado, A Body Corporate Three-dimensional mapping and therapy of prostate cancer
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
EP3316879A4 (en) * 2015-07-01 2019-01-23 TWI Biotechnology, Inc. TOPICAL FORMULATIONS OF RHEINE OR DIACEREIN, AND USES THEREOF

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
US5393898A (en) * 1991-06-25 1995-02-28 Madaus Ag Method of preparing diacetyl rhein
AU683044B2 (en) * 1992-12-23 1997-10-30 Saitec S.R.L. Process for preparing controlled release pharmaceutical forms and the forms thus obtained
US5652265A (en) * 1995-03-29 1997-07-29 Wisconsin Alumni Research Foundation Production of rhein and rhein derivatives
IT1276781B1 (it) * 1995-06-23 1997-11-03 Gentili Ist Spa Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie

Also Published As

Publication number Publication date
PT904061E (pt) 2003-02-28
JP2000505817A (ja) 2000-05-16
WO1998027965A1 (fr) 1998-07-02
DE69716261D1 (de) 2002-11-14
US6124358A (en) 2000-09-26
CN1211917A (zh) 1999-03-24
EP0904061B1 (fr) 2002-10-09
DK0904061T3 (da) 2003-01-27
IL125794A0 (en) 1999-04-11
JP4166834B2 (ja) 2008-10-15
FR2757397A1 (fr) 1998-06-26
DE69716261T2 (de) 2003-09-18
ES2184148T3 (es) 2003-04-01
FR2757397B1 (fr) 1999-03-05
CA2247520C (fr) 2007-03-27
EP0904061A1 (fr) 1999-03-31
IL125794A (en) 2000-12-06
ATE225649T1 (de) 2002-10-15
CA2247520A1 (fr) 1998-07-02
CN1128612C (zh) 2003-11-26

Similar Documents

Publication Publication Date Title
BR9707581A (pt) Composicao farmaceutica a base de reina ou de diacerreina processo para sua preparacao e utilizacao de reina ou diacerreina
BR9916307A (pt) Derivados quinolina
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
FI962589A0 (fi) 2,4-disulfofenyylibutyylinitroni, sen suolat ja niiden käyttö farmaseuttisina aineina
MY115662A (en) Novel compounds with analgesic effect
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
BR9405843A (pt) Processo para reduzir perda óssea e uso de um composto
ITMI911149A0 (it) Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
ATE275945T1 (de) Oral anzuwendende arzneizubereitung
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
BR9509975A (pt) Formulação farmacêutica
BR9809571A (pt) Composição medicinal e processo para produzì-la
ES2128043T3 (es) Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
BRPI9907025B8 (pt) polissacarídeos sintéticos e uso dos mesmos
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
HUP0100171A2 (hu) Endotelin-receptor-antagonisták alkalmazása elhízás leküzdésére szolgáló gyógyszerkészítmények előállítására
ES2062138T3 (es) Utilizacion de 5'-deoxi-5'-metiltioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas favorecedoras del crecimiento del cabello en sujetos adolecientes de calvicie.
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
SE9504662D0 (sv) New compounds
ES2061478T3 (es) Derivados de teofilin-metil-ditiolano y teofilin-metil-ditianilo, un metodo para su preparacion, y composiciones farmaceuticas que los contienen.
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time